LD-2 disclosure · 1st Quarter - Report
CRUCELL, NA
Client
- Name
- CRUCELL, NA
- Description
- Vaccine and therapeutic Product Research, Development and Manufacturing
- Location
- Netherlands
Registrant
- Description
- Business Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
Government appropriations and contracts in support of development of vaccines and therapeutic medical countermeasures against both naturally-occurring infectious diseases such as seasonal and pandemic influenza and staph aureus and potential bioterrorist threats from Ebola and Marburg filoviruses
Lobbyistsmr DONALD DALRYMPLE
Covered position (mr DONALD DALRYMPLE): Principal and Managing Director
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD) · Health & Human Services, Dept of (HHS) · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Natl Institutes of Health (NIH) · Homeland Security, Dept of (DHS) · Defense Threat Reduction Agency (DTRA)